Published date: 20 April 2018

This notice was replaced on 17 September 2018

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 17 September 2018, last edited 5 January 2021)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Vaccines - 33651600

Location of contract

Any region, Scotland, Wales, Northern Ireland

Value of contract

£0

Procurement reference

CM/PHV/16/5504

Published date

20 April 2018

Closing date

24 May 2018

Contract start date

1 June 2019

Contract end date

31 May 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of a vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 3 500 000 doses of vaccine.

More information

Previous notice about this procurement

Meningococcal C or ACWY vaccine

  • Future opportunity
  • Published 23 August 2017

Attachments

Additional text

This future opportunity was originally published 5 February 2016 under the Commercial Medicines Unit as the contact organisation. The original notice has now been withdrawn and this new notice reflects the contact address as Department of Health.

About the buyer

Address

Department of Health
2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

natalie.howell@dh.gsi.gov.uk